ID: ALA4593067

Max Phase: Preclinical

Molecular Formula: C22H16O3

Molecular Weight: 328.37

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  COc1cccc2c1ccc1c(/C=C/c3ccccc3)cc(=O)oc12

Standard InChI:  InChI=1S/C22H16O3/c1-24-20-9-5-8-19-18(20)13-12-17-16(14-21(23)25-22(17)19)11-10-15-6-3-2-4-7-15/h2-14H,1H3/b11-10+

Standard InChI Key:  BXCWHBAQRKQDDB-ZHACJKMWSA-N

Associated Targets(Human)

DNA ligase 1 262 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 328.37Molecular Weight (Monoisotopic): 328.1099AlogP: 5.13#Rotatable Bonds: 3
Polar Surface Area: 39.44Molecular Species: NEUTRALHBA: 3HBD: 0
#RO5 Violations: 1HBA (Lipinski): 3HBD (Lipinski): 0#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: CX LogP: 4.66CX LogD: 4.66
Aromatic Rings: 4Heavy Atoms: 25QED Weighted: 0.39Np Likeness Score: 0.30

References

1. Saquib M, Ansari MI, Johnson CR, Khatoon S, Kamil Hussain M, Coop A..  (2019)  Recent advances in the targeting of human DNA ligase I as a potential new strategy for cancer treatment.,  182  [PMID:31499361] [10.1016/j.ejmech.2019.111657]

Source